LLMpediaThe first transparent, open encyclopedia generated by LLMs

syndrome of inappropriate antidiuretic hormone secretion

Generated by Llama 3.3-70B
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: SCLC Hop 4
Expansion Funnel Raw 97 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted97
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
syndrome of inappropriate antidiuretic hormone secretion
NameSyndrome of Inappropriate Antidiuretic Hormone Secretion
Diseasesdb12048
Icd9253.6
Icd10E22.2

syndrome of inappropriate antidiuretic hormone secretion is a condition characterized by the excessive release of antidiuretic hormone (ADH) from the hypothalamus or posterior pituitary gland, leading to water retention and resulting in hyponatremia, as seen in patients with small cell lung cancer treated at Memorial Sloan Kettering Cancer Center and University of California, San Francisco. This condition was first described by Schwartz and Bartter in 1957, and has since been studied extensively by researchers at Harvard University and Stanford University. The syndrome is often associated with various underlying conditions, including tuberculosis treated with isoniazid at Johns Hopkins University and Columbia University, and pneumonia diagnosed at Massachusetts General Hospital and University of Pennsylvania.

Definition

The definition of syndrome of inappropriate antidiuretic hormone secretion involves the excessive secretion of ADH, leading to an inappropriate increase in water reabsorption in the kidneys, as studied by researchers at National Institutes of Health and University of Oxford. This results in dilutional hyponatremia, characterized by a low sodium level in the blood, often seen in patients with heart failure treated at Cleveland Clinic and Mayo Clinic. The condition is typically diagnosed in patients with euvolemic hyponatremia, where the blood volume is normal, as opposed to hypovolemic hyponatremia or hypervolemic hyponatremia, as described by American Heart Association and European Society of Cardiology. The syndrome can be life-threatening if left untreated, and requires prompt medical attention at institutions such as NewYork-Presbyterian Hospital and University of California, Los Angeles.

Pathophysiology

The pathophysiology of syndrome of inappropriate antidiuretic hormone secretion involves the abnormal secretion of ADH, which binds to vasopressin receptors in the kidneys, leading to increased water reabsorption, as researched by scientists at University of Cambridge and Karolinska Institutet. This results in an increase in blood volume and a subsequent decrease in sodium levels, often seen in patients with liver disease treated at University of Chicago and Duke University. The condition can also be exacerbated by the use of certain medications, such as thiazide diuretics and selective serotonin reuptake inhibitors, as reported by Food and Drug Administration and European Medicines Agency. The syndrome is often associated with underlying conditions, such as stroke and traumatic brain injury, which can disrupt the normal regulation of ADH secretion, as studied by researchers at University of Toronto and McGill University.

Causes

The causes of syndrome of inappropriate antidiuretic hormone secretion are diverse and can be categorized into several groups, including central nervous system disorders, such as meningitis treated at Boston Children's Hospital and Great Ormond Street Hospital, and encephalitis diagnosed at University of Washington and University of Michigan. Other causes include lung disease, such as pneumonia and tuberculosis, which can stimulate the release of ADH, as researched by scientists at Centers for Disease Control and Prevention and World Health Organization. Certain medications, such as chlorpropamide and carbamazepine, can also cause the syndrome, as reported by National Institute of Neurological Disorders and Stroke and American Academy of Neurology. Additionally, the syndrome can be associated with cancer, particularly small cell lung cancer and lymphoma, which can produce ectopic ADH, as studied by researchers at National Cancer Institute and American Cancer Society.

Diagnosis

The diagnosis of syndrome of inappropriate antidiuretic hormone secretion involves a combination of clinical evaluation, laboratory tests, and imaging studies, as performed at Hospital of the University of Pennsylvania and University of California, San Diego. The diagnosis is typically made in patients with euvolemic hyponatremia, where the blood volume is normal, and other causes of hyponatremia have been excluded, as described by American College of Physicians and European Society of Clinical Microbiology and Infectious Diseases. Laboratory tests, such as serum sodium and urine osmolality, can help confirm the diagnosis, as researched by scientists at University of Wisconsin-Madison and University of Edinburgh. Imaging studies, such as computed tomography and magnetic resonance imaging, can help identify underlying conditions, such as tumors and infections, which may be causing the syndrome, as reported by Radiological Society of North America and European Society of Radiology.

Treatment

The treatment of syndrome of inappropriate antidiuretic hormone secretion depends on the underlying cause and severity of the condition, as determined by healthcare professionals at Cedars-Sinai Medical Center and University of Texas Southwestern Medical Center. In mild cases, treatment may involve fluid restriction and monitoring of serum sodium levels, as recommended by American Heart Association and European Society of Cardiology. In more severe cases, treatment may involve the use of medications, such as vasopressin receptor antagonists and urea, to increase urine output and correct hyponatremia, as researched by scientists at University of California, Berkeley and University of Illinois at Urbana-Champaign. In some cases, treatment may also involve addressing the underlying condition, such as tumor resection or antibiotic therapy, as performed at MD Anderson Cancer Center and University of Pittsburgh.

Prognosis

The prognosis of syndrome of inappropriate antidiuretic hormone secretion depends on the underlying cause and severity of the condition, as studied by researchers at University of Southern California and University of North Carolina at Chapel Hill. In general, the prognosis is good if the underlying cause is identified and treated promptly, as reported by National Institute of Diabetes and Digestive and Kidney Diseases and American Society of Nephrology. However, if left untreated, the syndrome can lead to severe hyponatremia, which can result in seizures, coma, and even death, as described by World Health Organization and Centers for Disease Control and Prevention. Therefore, prompt medical attention is essential to prevent long-term complications and improve outcomes, as emphasized by American Medical Association and European Medical Association. Category:Endocrine disorders

Some section boundaries were detected using heuristics. Certain LLMs occasionally produce headings without standard wikitext closing markers, which are resolved automatically.